TBX1 and paraganglioma: In order to analyze whether brachyury may be also used for the differentiation of renal HBL from adrenal carcinoma or paraganglioma, we tested the expression of this marker in five adrenal carcinomas as well as in five paraganglioma (unpublished data) (see [26] for details on immunohistochemical methods).